Merck Doubles Down On Diabetes In China, Launches Janumet
This article was originally published in PharmAsia News
Executive Summary
China, home to the world’s largest diabetes population, sees another major product launch as multinationals jockey for position in the DPP-4 space in anticipation of the next NDRL revision.